FI20155554A - Menetelmä rekombinantteja nefrokystiinin (NPHP1) SH3-domeenin johdannaisia käsittävän kirjaston valmistamiseksi - Google Patents

Menetelmä rekombinantteja nefrokystiinin (NPHP1) SH3-domeenin johdannaisia käsittävän kirjaston valmistamiseksi

Info

Publication number
FI20155554A
FI20155554A FI20155554A FI20155554A FI20155554A FI 20155554 A FI20155554 A FI 20155554A FI 20155554 A FI20155554 A FI 20155554A FI 20155554 A FI20155554 A FI 20155554A FI 20155554 A FI20155554 A FI 20155554A
Authority
FI
Finland
Prior art keywords
nephrocystin
nphp1
recombinant
library
derivatives
Prior art date
Application number
FI20155554A
Other languages
English (en)
Swedish (sv)
Other versions
FI126633B (fi
Inventor
Kalle Saksela
Original Assignee
Next Biomed Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Next Biomed Therapies Oy filed Critical Next Biomed Therapies Oy
Priority to FI20155554A priority Critical patent/FI126633B/fi
Priority to EP21150093.9A priority patent/EP3851536A1/en
Priority to CA2991953A priority patent/CA2991953A1/en
Priority to US15/742,934 priority patent/US11060084B2/en
Priority to PCT/FI2016/050509 priority patent/WO2017009533A1/en
Priority to EP16741975.3A priority patent/EP3320095B1/en
Publication of FI20155554A publication Critical patent/FI20155554A/fi
Application granted granted Critical
Publication of FI126633B publication Critical patent/FI126633B/fi
Priority to US17/367,723 priority patent/US20210395726A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI20155554A 2015-07-10 2015-07-10 Menetelmä rekombinantteja nefrokystiinin (NPHP1) SH3-domeenin johdannaisia käsittävän kirjaston valmistamiseksi FI126633B (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20155554A FI126633B (fi) 2015-07-10 2015-07-10 Menetelmä rekombinantteja nefrokystiinin (NPHP1) SH3-domeenin johdannaisia käsittävän kirjaston valmistamiseksi
EP21150093.9A EP3851536A1 (en) 2015-07-10 2016-07-08 Sh3 domain derivatives
CA2991953A CA2991953A1 (en) 2015-07-10 2016-07-08 Sh3 domain derivatives
US15/742,934 US11060084B2 (en) 2015-07-10 2016-07-08 SH3 domain derivatives
PCT/FI2016/050509 WO2017009533A1 (en) 2015-07-10 2016-07-08 Sh3 domain derivatives
EP16741975.3A EP3320095B1 (en) 2015-07-10 2016-07-08 Sh3 domain derivatives
US17/367,723 US20210395726A1 (en) 2015-07-10 2021-07-06 SH3 domain derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20155554A FI126633B (fi) 2015-07-10 2015-07-10 Menetelmä rekombinantteja nefrokystiinin (NPHP1) SH3-domeenin johdannaisia käsittävän kirjaston valmistamiseksi

Publications (2)

Publication Number Publication Date
FI20155554A true FI20155554A (fi) 2017-01-11
FI126633B FI126633B (fi) 2017-03-15

Family

ID=56511599

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20155554A FI126633B (fi) 2015-07-10 2015-07-10 Menetelmä rekombinantteja nefrokystiinin (NPHP1) SH3-domeenin johdannaisia käsittävän kirjaston valmistamiseksi

Country Status (5)

Country Link
US (2) US11060084B2 (fi)
EP (2) EP3851536A1 (fi)
CA (1) CA2991953A1 (fi)
FI (1) FI126633B (fi)
WO (1) WO2017009533A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021252164A1 (en) 2020-04-09 2022-12-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
CN113967257A (zh) * 2020-07-24 2022-01-25 上海交通大学医学院附属瑞金医院 一种c-Src SH3 RT-loop作为靶点用于抗血栓
WO2023089243A1 (en) * 2021-11-19 2023-05-25 Pandemblock Oy Sh3 domain derivatives targeting receptor binding domain (rbd) of sars-cov-2 spike protein

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504201A (ja) * 1994-10-07 2000-04-11 ヘルシンキ、ユニバーシティ、ライセンシング、リミテッド、オサケ、ユキチュア 細胞質性チロシンキナーゼ
JPH11509172A (ja) * 1995-04-07 1999-08-17 サイトジェン・コーポレーション 目的の機能ドメインを有するポリペプチドおよびそれの同定および利用法
US6309820B1 (en) * 1995-04-07 2001-10-30 University Of North Carolina At Chapel Hill Polypeptides having a functional domain of interest and methods of identifying and using same
US6794144B1 (en) 1999-05-26 2004-09-21 Licentia Ltd. Methods and materials for generating SH3 domains with tailored binding properties
GB0025804D0 (en) * 2000-10-20 2000-12-06 Glaxo Group Ltd Assay
EP1955227A2 (en) * 2005-09-07 2008-08-13 Board of Regents, The University of Texas System Methods of using and analyzing biological sequence data
EP1892248A1 (en) 2006-08-21 2008-02-27 Eidgenössische Technische Hochschule Zürich Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase
CA2865597A1 (en) 2012-03-16 2013-09-19 Covagen Ag Novel binding molecules with antitumoral activity
EA201592006A1 (ru) 2013-04-19 2016-03-31 Коваген Аг Новые биспецифические связывающие молекулы с противоопухолевой активностью

Also Published As

Publication number Publication date
FI126633B (fi) 2017-03-15
US20210395726A1 (en) 2021-12-23
WO2017009533A1 (en) 2017-01-19
US20180230456A1 (en) 2018-08-16
US11060084B2 (en) 2021-07-13
EP3851536A1 (en) 2021-07-21
EP3320095B1 (en) 2021-01-06
EP3320095A1 (en) 2018-05-16
CA2991953A1 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
IL259560A (en) Inhibitors of the menin-mll interaction
DK3464271T3 (da) Pyrazolderivater som plasma-kallikreininhibitorer
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3302448T3 (da) Erstattede heterocyclylafledninger som cdk-inhibitore
DK3319956T3 (da) Substituerede oxopyridinderivater
DK3371190T3 (da) Heterocykliske forbindelser som pi3k-gamma-inhibitorer
SG11201706729SA (en) Derivatives of sobetirome
DK3442972T3 (da) Bromdomænehæmmere
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3271349T3 (da) Benzimidazolederivater som bromodomain-inhibitorer
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3341379T3 (da) EZH2-hæmmere
HUE056357T2 (hu) Szobetirom származékok
MA43367A (fr) Inhibiteurs de métallo-bêta-lactamases
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3166611T3 (da) Fremgangsmåde til fremstilling af 4-alkoxy-3-hydroxypicolinsyrer
DK3186241T3 (da) Prober til billeddannelse af huntington-protein
FI20155728A (fi) Menetelmä kiinteän ligniinin valmistamiseksi
DK3319970T3 (da) Pyrido-oxazinonderivater som tnap-hæmmere
ITUB20152349A1 (it) Metodo di dosaggio autocalibrato
FI20155554A (fi) Menetelmä rekombinantteja nefrokystiinin (NPHP1) SH3-domeenin johdannaisia käsittävän kirjaston valmistamiseksi
EP3526216C0 (en) BENZOTHIAZOLE DERIVATIVES AS DYRK1 INHIBITORS
DK3481826T3 (da) Tyrosinkinaseinhibitorer
DK3380465T3 (da) Diaminopyridinderivativer

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 126633

Country of ref document: FI

Kind code of ref document: B